These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10895833)

  • 1. Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction.
    Gerstein HC
    Diabetes Care; 2000 Jul; 23(7):882-3. PubMed ID: 10895833
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
    Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Furberg CD
    Diabetes Care; 2000 Jul; 23(7):888-92. PubMed ID: 10895836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When to treat the hypertensive diabetic patient.
    Fuller JH
    J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of the ACE inhibitor lisinopril on blood pressure, metabolism, and renal function parameter in hypertensive type II diabetic patients: a postmarketing surveillance study.
    Hasslacher C
    J Diabetes Complications; 1996; 10(3):136-8. PubMed ID: 8807458
    [No Abstract]   [Full Text] [Related]  

  • 5. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of ACE inhibitors on diabetic patients without renal disease.
    Kirpichnikov D; Winer N; Sowers JR
    Curr Diab Rep; 2002 Feb; 2(1):21-5. PubMed ID: 12643119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
    Parving HH
    J Diabetes Complications; 1996; 10(3):133-5. PubMed ID: 8807457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors and cardiovascular protection in diabetes.
    Donnelly R
    Diabetes Obes Metab; 2004 Nov; 6(6):399-401. PubMed ID: 15479215
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood pressure control in diabetic nephropathy.
    Katayama S
    Contrib Nephrol; 2001; (134):113-9. PubMed ID: 11665281
    [No Abstract]   [Full Text] [Related]  

  • 10. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 11. The diabetic hypertensive (or hypertensive diabetic)--a compelling need to optimize blood pressure.
    Carruthers SG
    Adv Exp Med Biol; 2001; 498():119-25. PubMed ID: 11900359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
    Smahelová A
    Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood pressure control in type 2 diabetes mellitus.
    Krantz MJ
    Ann Intern Med; 2004 Mar; 140(6):487; author reply 487-8. PubMed ID: 15023718
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes technology news. Calcium antagonists aid high blood pressure control.
    Walczak IM
    Diabetes Technol Ther; 2003; 5(3):510-1. PubMed ID: 12838935
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus, the renin-angiotensin system, and angiotensin-converting enzyme inhibition.
    Björck S; Aurell M
    Nephron; 1990; 55 Suppl 1():10-20. PubMed ID: 2189073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.
    Van Gaal LF; Caterson ID; Coutinho W; Finer N; Maggioni AP; Sharma AM; Torp-Pedersen C; Ge H; Moran SA; Shepherd GM; James WP;
    Diabetes Obes Metab; 2010 Jan; 12(1):26-34. PubMed ID: 19758358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.
    So WY; Ozaki R; Chan NN; Tong PC; Ho CS; Lam CW; Ko GT; Chow CC; Chan WB; Ma RC; Chan JC
    Hypertension; 2004 Sep; 44(3):294-9. PubMed ID: 15249544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic microangiopathy and systemic blood pressure].
    Ravid M
    Harefuah; 1995 Feb; 128(3):175-8. PubMed ID: 7759011
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing the diabetic hypertensive patient.
    Poulter NR
    J Diabetes Complications; 1996; 10(3):141-3. PubMed ID: 8807460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.